Mirapex (pramipexole Dihydrochloride recalls

The FDA has published 1 recall involving Mirapex (pramipexole Dihydrochloride since 2019. The latest was reported on 20 Mar 2019. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 20 Mar 2019

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why mirapex (pramipexole dihydrochloride is recalled

Potency & Assay1100%

Companies

Boehringer Ingelheim Pharmaceuticals1100%

By year

20191100%

All mirapex (pramipexole dihydrochloride recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
20 Mar 2019Drug	CLASS III	Mirapex (pramipexole dihydrochloride) Tablets recalled	Boehringer Ingelheim Pharmaceuticals	Potency & Assay	Nationwide

Should you stop taking Mirapex (pramipexole Dihydrochloride?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.